Abstract
Johannes Czernin, MD, editor in chief of The Journal of Nuclear Medicine, recently initiated a series of recorded discussions with leaders in nuclear medicine and molecular imaging. This month he asked Ken Herrmann, MD, MBA, a professor of nuclear medicine at the Universitatsklinikum Essen (Germany
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have